PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

15 registration certificates of medicines have been withdrawn from the State Register

The Ministry of Health of the Russian Federation has revoked registration certificates for 15 drugs based on applications from their owners. Of these, 13 belonged to JSC Pharmstandard-Tomskkhimpharm, the rest belonged to JSC Sanofi Russia. Information about this appeared on the GRLS website.

Recalled drugs of JSC Pharmstandard-Tomskkhimpharm: 

“Ethyl alcohol” ((ethanol), LSR-008197/08 dated 10/16/2008);

“Citramon P” (LSR-000021 dated 03/28/2007);

“Furosemide” ((furosemide) LS-000488 dated 11/18/2009);

Prednisone (prednisone) LSR-003276/07 dated 10/17/2007);

“Paracetamol” ((paracetamol) LSR-000062 dated 05/10/2007);

Pantocrine (LSR-003253/07 dated 17.10.2007);

“Nitrosorbide” ((isosorbide dinitrate) LSR-003429/07 dated 10/26/2007);

Peppermint tincture (LSR-003434/07 dated 10/26/2007);

“Levomycetin” ((chloramphenicol) LS-001979 dated 07/9/2010);

“Potassium orotate” ((orotic acid) LSR-003254/07 dated 17.10.2007);

Hawthorn tincture (LS-002044 from 08/25/2009);

“Acetylsalicylic acid” ((acetylsalicylic acid) R N003094/01 dated 12/15/2008);

“Analgin” ((sodium metamizole), P N001244/01 dated 01/23/2008).

Recalled drugs of Sanofi Russia JSC:

“Troxerutin Sanofi” ((troxerutin) N N015161/01 dated 08/13/2008);

“Tritatse” ((ramipril) LSR-008998/09 dated 09.11.2009).

All drugs excluded from the GRLS have registered analogues on the Russian market.

Current news

  • March 31, 2025

    Russian spending on antidepressants reached nearly 3 billion rubles since the beginning of the year

    Pharmacy chains earned 2.8 billion rubles from antidepressant sales in January-February 2025. A total of…

  • March 31, 2025

    The State Duma rejected the bill on accelerated market entry for generics

    On March 20, deputies of the State Duma rejected in the first reading a bill…

  • March 31, 2025

    Russia to increase production of infliximab-based medicines

    The company “Pharmapark” plans to steadily increase its production volumes. Specifically, over 30,000 packages of…

  • March 31, 2025

    A unified database for veterinary drugs will be launched in EAEU countries

    The Collegium of the Eurasian Economic Commission (EEC) has approved the creation of a unified…

  • March 31, 2025

    MSD will pay up to $2 billion for Chinese heart medication

    One of the world’s largest pharmaceutical companies, MSD, will pay up to $2 billion for…

LLC “BioJet”. all rights reserved

  • Legal information